Target Price | $180.00 |
Price | $169.54 |
Potential | 6.17% |
Number of Estimates | 24 |
24 Analysts have issued a price target Procter & Gamble 2025 . The average Procter & Gamble target price is $180.00. This is 6.17% higher than the current stock price. The highest price target is $200.00 17.97% , the lowest is $160.00 5.63% . | |
A rating was issued by 30 analysts: 16 Analysts recommend Procter & Gamble to buy, 13 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Procter & Gamble stock has an average upside potential 2025 of 6.17% . Most analysts recommend the Procter & Gamble stock at Purchase. |
21 Analysts have issued a sales forecast Procter & Gamble 2025 . The average Procter & Gamble sales estimate is $85.7b . This is 2.13% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $86.5b 3.13% , the lowest is $85.3b 1.64% .
This results in the following potential growth metrics:
2024 | $84.0b | 2.48% |
---|---|---|
2025 | $85.7b | 1.97% |
2026 | $88.9b | 3.73% |
2027 | $92.3b | 3.79% |
2028 | $96.5b | 4.58% |
19 Analysts have issued an Procter & Gamble EBITDA forecast 2025. The average Procter & Gamble EBITDA estimate is $24.3b . This is 6.81% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $25.3b 11.49% , the lowest is $23.7b 4.47% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $23.1b | 9.60% |
---|---|---|
2025 | $24.3b | 5.02% |
2026 | $25.8b | 6.19% |
2027 | $27.3b | 6.09% |
2028 | $28.7b | 5.07% |
2024 | 27.48% | 6.95% |
---|---|---|
2025 | 28.30% | 2.98% |
2026 | 28.97% | 2.37% |
2027 | 29.62% | 2.24% |
2028 | 29.76% | 0.47% |
10 Procter & Gamble Analysts have issued a net profit forecast 2025. The average Procter & Gamble net profit estimate is $15.9b . This is 16.69% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $16.8b 22.93% , the lowest is $15.3b 11.90% .
This results in the following potential growth metrics and future Net Margins:
2024 | $14.2b | 2.03% |
---|---|---|
2025 | $15.9b | 12.42% |
2026 | $17.6b | 10.41% |
2027 | $18.9b | 7.44% |
2028 | $19.9b | 5.36% |
2024 | 16.87% | 0.43% |
---|---|---|
2025 | 18.60% | 10.26% |
2026 | 19.80% | 6.45% |
2027 | 20.49% | 3.48% |
2028 | 20.65% | 0.78% |
10 Analysts have issued a Procter & Gamble forecast for earnings per share. The average Procter & Gamble <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is $6.77 . This is 16.72% higher than earnings per share in the financial year 2024. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is $7.13 22.93% , the lowest is $6.49 11.90% .
This results in the following potential growth metrics and future valuations:
2024 | $6.02 | 2.03% |
---|---|---|
2025 | $6.77 | 12.46% |
2026 | $7.47 | 10.34% |
2027 | $8.03 | 7.50% |
2028 | $8.46 | 5.35% |
Current | 29.24 | 18.77% |
---|---|---|
2025 | 25.05 | 14.33% |
2026 | 22.69 | 9.42% |
2027 | 21.12 | 6.92% |
2028 | 20.04 | 5.11% |
Based on analysts' sales estimates for 2025, the Procter & Gamble stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of 4.95 and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of 4.66 .
This results in the following potential growth metrics and future valuations:
Current | 5.06 | 9.76% |
---|---|---|
2025 | 4.95 | 2.13% |
2026 | 4.77 | 3.60% |
2027 | 4.60 | 3.65% |
2028 | 4.40 | 4.38% |
Current | 4.76 | 11.03% |
---|---|---|
2025 | 4.66 | 2.08% |
2026 | 4.49 | 3.60% |
2027 | 4.33 | 3.65% |
2028 | 4.14 | 4.37% |
Procter & Gamble...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.